Unraveling the Core: Hub Genes Bridging Familial and Sporadic Parkinson’s Disease

No abstract is available for this paper.

• Publication year

  2025

• Venue

  bioRxiv

• Publication date

  2025-08-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00415-025-13429-xPMID 41670743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases—an update

  2025cited by this paper
• Septin 3 regulates memory and L-LTP-dependent extension of endoplasmic reticulum into spines.

  2025cited by this paper
• Correction: TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation.

  2025cited by this paper
• The dual nature of neuroinflammation in networked brain

  2025cited by this paper
• Antioxidant, neuroprotective, and neuroblastoma cells (SH-SY5Y) differentiation effects of melanins and arginine-modified melanins from Daedaleopsis tricolor and Fomes fomentarius

  2024cited by this paper
• Multi-omics analysis reveals the genetic aging landscape of Parkinson’s disease

  2024cited by this paper
• Integrating bioinformatics and machine learning to uncover lncRNA LINC00269 as a key regulator in Parkinson's disease via pyroptosis pathways

  2024cited by this paper
• Glutathione S-transferase: A keystone in Parkinson's disease pathogenesis and therapy.

  2024cited by this paper
• Cytoprotective effect of melatonin against MPP+ toxicity in SH-SY5Y cells: Role sharing of two types of antioxidative activities of melatonin.

  2024cited by this paper
• Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease.

  2024cited by this paper
• The Effect of glna Loss on the Physiological and Pathological Phenotype of Parkinson's Disease C. elegans

  2024cited by this paper
• Integrated Transcriptomic and Machine Learning Analysis Identifies EAF2 as a Diagnostic Biomarker and Key Pathogenic Factor in Parkinson’s Disease

  2024cited by this paper
• Circulating blood circular RNA in Parkinson’s Disease; from involvement in pathology to diagnostic tools in at-risk individuals

  2024cited by this paper
• Identification of copper metabolism-related markers in Parkinson’s disease

  2024cited by this paper
• Identification and validation of biomarkers related to mitochondria during ex vivo lung perfusion for lung transplants based on machine learning algorithm.

  2024cited by this paper
• Single-cell transcriptomic and proteomic analysis of Parkinson's disease brains.

  2024cited by this paper
• TMEM106B knockdown exhibits a neuroprotective effect in Parkinson's disease models via regulating autophagy-lysosome pathway.

  2024cited by this paper
• Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study

  2024cited by this paper
• Deciphering the role of heat shock protein HSPA1L: biomarker discovery and prognostic insights in Parkinson's disease and glioma.

  2024cited by this paper
• Resveratrol and ceftriaxone encapsulated in hybrid nanoparticles to prevent dopaminergic neurons from degeneration for Parkinson's disease treatment.

  2024cited by this paper
• Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson’s disease patients

  2024cited by this paper
• Exploring the hub Genes and Potential Mechanisms of Complement system-related Genes in Parkinson Disease: Based on Transcriptome Sequencing and Mendelian Randomization

  2024cited by this paper
• Integration of bioinformatics and multi-layered experimental validation reveals novel functions of acetylation-related genes in intervertebral disc degeneration.

  2024cited by this paper
• A nomoscore of four genes for predicting the rupture risk in abdominal aortic aneurysm patients with osteoarthritis.

  2024cited by this paper
• Identification of key mitochondria-related genes and their potential crosstalk role with immune pattern in Idiopathic pulmonary fibrosis.

  2024cited by this paper
• Integrated bioinformatic analysis and experimental validation for exploring the key immune checkpoint of COPD.

  2024cited by this paper
• Jujubae Fructus extract prolongs lifespan and improves stress tolerance in Caenorhabditis elegans dependent on DAF-16/SOD-3

  2024cited by this paper
• Developing and experimental validating a B cell exhaustion-related gene signature to assess prognosis and immunotherapeutic response in bladder cancer.

  2024cited by this paper
• Ferrostatin-1 mitigates cellular damage in a ferroptosis-like environment in Caenorhabditis elegans.

  2024cited by this paper
• Identification and preliminary validation of differently expressed genes as candidate biomarkers associated with atherosclerosis.

  2024cited by this paper
• Identification and validation of ferroptosis-related lncRNAs signature in intervertebral disc degeneration.

  2024influential reference
• Pathogenesis of DJ-1/PARK7-Mediated Parkinson’s Disease

  2024cited by this paper
• Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils

  2024cited by this paper
• Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions

  2023cited by this paper
• SH-SY5Y Cell Line In Vitro Models for Parkinson Disease Research-Old Practice for New Trends.

  2023cited by this paper
• Involvement of Mitochondria in Parkinson’s Disease

  2023cited by this paper
• Correction: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

  2023cited by this paper
• Association Between Bipolar Disorder and Parkinson's Disease.

  2023cited by this paper
• Neuroinflammation is linked to dementia risk in Parkinson’s disease

  2023cited by this paper
• Androgen Receptor in Hormone Receptor-Positive Breast Cancer

  2023cited by this paper
• Leucine-rich repeat kinase 2 at a glance

  2023cited by this paper
• Upregulation of immunoproteasome PSMB8 is associated with Parkinson's disease.

  2023cited by this paper
• Parkinson’s Disease: Exploring Different Animal Model Systems

  2023cited by this paper
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

  2023cited by this paper
• HCN channels and absence seizures.

  2023cited by this paper
• Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer

  2023cited by this paper
• Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson's disease dementia using bioinformatics

  2023cited by this paper
• Transcriptome datasets of neural progenitors and neurons differentiated from induced pluripotent stem cells of healthy donors and Parkinson's disease patients with mutations in the PARK2 gene

  2022cited by this paper
• Functional requirements for a Samd14-capping protein complex in stress erythropoiesis

  2022cited by this paper
• [Parkinson's disease].

  2022cited by this paper
• BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment

  2022cited by this paper
• Mapping Proteome and Lipidome Changes in Early-Onset Non-Alcoholic Fatty Liver Disease Using Hepatic 3D Spheroids

  2022cited by this paper
• Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson’s disease

  2022cited by this paper
• DNA methylation as a mediator of genetic and environmental influences on Parkinson’s disease susceptibility: Impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome

  2022cited by this paper
• Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease

  2022cited by this paper
• Cellular reprogramming with ATOH1, GFI1, and POU4F3 implicate epigenetic changes and cell-cell signaling as obstacles to hair cell regeneration in mature mammals

  2022cited by this paper
• Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease

  2022cited by this paper
• GBA Variants and Parkinson Disease: Mechanisms and Treatments

  2022cited by this paper
• Connexin43 inhibition attenuated dopaminergic neuronal loss in the lipopolysaccharide-induced mice model of Parkinson's disease.

  2022cited by this paper
• BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma

  2021cited by this paper
• Non-Genetic Risk Factors for Parkinson’s Disease: An Overview of 46 Systematic Reviews

  2021cited by this paper
• JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles

  2021cited by this paper
• ARE ION CHANNELS POTENTIAL THERAPEUTIC TARGETS FOR PARKINSON'S DISEASE?

  2021cited by this paper
• OUP accepted manuscript

  2021cited by this paper
• Rab6b localizes to the Golgi complex in murine macrophages and promotes tumor necrosis factor release in response to mycobacterial infection

  2021cited by this paper
• Multiomic Analyses of Dopaminergic Neurons Isolated from Human Substantia Nigra in Parkinson’s Disease: A Descriptive and Exploratory Study

  2021cited by this paper
• Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson’s Disease

  2021cited by this paper
• Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis.

  2020cited by this paper
• Two single nucleotide polymorphisms in IL13 and IL13RA1 from individuals with idiopathic Parkinson's disease increase cellular susceptibility to oxidative stress.

  2020cited by this paper
• Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease

  2020cited by this paper
• Healthspan Enhancement by Olive Polyphenols in C. elegans Wild Type and Parkinson’s Models

  2020cited by this paper
• Vesicle trafficking and lipid metabolism in synucleinopathy

  2020cited by this paper
• gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler

  2020cited by this paper
• Expression of the pacemaker channel HCN4 in excitatory interneurons in the dorsal horn of the murine spinal cord

  2020cited by this paper
• Classic and evolving animal models in Parkinson's disease.

  2020cited by this paper
• Gene4PD: A Comprehensive Genetic Database of Parkinson’s Disease

  2020cited by this paper
• Disease

  2020cited by this paper
• Immunoproteasome

  2020cited by this paper
• DEGENERATION

  2020cited by this paper
• Viability

  2020cited by this paper
• LRRK2 links genetic and sporadic Parkinson's disease.

  2019cited by this paper
• Found in Translation: The Utility of C. elegans Alpha-Synuclein Models of Parkinson’s Disease

  2019cited by this paper
• DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood

  2019cited by this paper
• Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease

  2019cited by this paper
• Overexpression of Forkhead box C1 attenuates oxidative stress, inflammation and apoptosis in chronic obstructive pulmonary disease

  2019cited by this paper
• Biallelic intragenic duplication in ADGRB3 (BAI3) gene associated with intellectual disability, cerebellar atrophy, and behavioral disorder

  2019cited by this paper
• Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease

  2019cited by this paper
• Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease

  2019cited by this paper
• NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis

  2019cited by this paper
• Spermine protects alpha-synuclein expressing dopaminergic neurons from manganese-induced degeneration

  2018cited by this paper
• Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process

  2018cited by this paper
• Modeling Parkinson’s Disease in C. elegans

  2018cited by this paper
• A Comprehensive Analysis of the Association Between SNCA Polymorphisms and the Risk of Parkinson's Disease

  2018cited by this paper
• Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220

  2018cited by this paper
• A novel gene-diet pair modulates C. elegans aging

  2018influential reference
• The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment

  2017cited by this paper
• Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

  2017cited by this paper
• Deciphering the pathways that protect from IL‐13‐mediated potentiation of oxidative stress‐induced dopaminergic nerve cell death

  2017cited by this paper
• Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin

  2017cited by this paper
• The SH-SY5Y cell line in Parkinson’s disease research: a systematic review

  2017cited by this paper

• No citing papers are available for this paper.